BCR-ABL1 also induces S-phase kinase-associated protein 2 (Skp2) expression to promote proliferation of CML cells by the PI3K-AKT-mTOR pathway [103]. The gene discussed is AKT1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.